Ovintiv Inc.
For the period ended Mar 31, 2026. Filed May 11, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 11, 2026
OVV$61.60+1.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statement of Cash Flows
| Three Months Ended | |||||
|---|---|---|---|---|---|
| March 31, | |||||
| (US$ millions) · 2026 · 2025 | |||||
| Operating Activities | |||||
| Net earnings (loss) | $(630) | $(159) | |||
| Depreciation, depletion and amortization | 561 | 545 | |||
| Impairments | (Note 10) | 1,485 | 730 | ||
| Accretion of asset retirement obligation | 7 | 6 | |||
| Deferred income taxes | (Note 7) | (210) | (77) | ||
| Unrealized (gain) loss on risk management | (Note 20) | 53 | 46 | ||
| Unrealized foreign exchange (gain) loss | (Note 6) | (1) | (45) | ||
| Foreign exchange (gain) loss on settlements | (Note 6) | (1) | (42) | ||
| Other | (25) | - | |||
| Net change in other assets and liabilities | (14) | (11) | |||
| Net change in non-cash working capital | (Note 21) | (169) | (120) | ||
| Cash From (Used in) Operating Activities | 1,056 | 873 | |||
| Investing Activities | |||||
| Capital expenditures | (Note 3) | (605) | (617) | ||
| Acquisitions | (Note 8) | (7) | (2,310) | ||
| Corporate acquisition, net of cash acquired | (Note 9) | (1,192) | - | ||
| Proceeds from divestitures | (Note 8) | 7 | 1,884 | ||
| Net change in investments and other | 59 | 148 | |||
| Cash From (Used in) Investing Activities | (1,738) | (895) | |||
| Financing Activities | |||||
| Net issuance (repayment) of revolving debt | (Note 12) | 297 | 85 | ||
| Issuance of debt under the Term Credit Agreement | (Notes 9, 12) | 1,151 | - | ||
| Repayment of long-term debt | (Note 12) | (459) | - | ||
| Purchase of shares of common stock | (Note 14) | (84) | - | ||
| Dividends on shares of common stock | (Note 14) | (85) | (78) | ||
| Other | (148) | (19) | |||
| Cash From (Used in) Financing Activities | 672 | (12) | |||
| Foreign Exchange Gain (Loss) on Cash, Cash Equivalents | |||||
| and Restricted Cash Held in Foreign Currency | 1 | - | |||
| Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash | (9) | (34) | |||
| Cash, Cash Equivalents and Restricted Cash, Beginning of Year | 35 | 42 | |||
| Cash, Cash Equivalents and Restricted Cash, End of Period | $26 | $8 | |||
| Cash, End of Period | $23 | $7 | |||
| Cash Equivalents, End of Period | 3 | 1 | |||
| Restricted Cash, End of Period | - | - | |||
| Cash, Cash Equivalents and Restricted Cash, End of Period | $26 | $8 | |||
| Supplementary Cash Flow Information | (Note 21) | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.